Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC

BACKGROUND: The Oral Care BC-trial reported that professional oral care (POC) reduces the incidence and severity of oral mucositis in patients receiving everolimus (EVE) and exemestane (EXE). However, the effect of POC on clinical response among patients receiving EVE and EXE was not established. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatsukasa, Katsuhiko, Niikura, Naoki, Kashiwabara, Kosuke, Amemiya, Takeshi, Watanabe, Ken-ichi, Hata, Hironobu, Kikawa, Yuichiro, Taniike, Naoki, Yamanaka, Takashi, Mitsunaga, Sachiyo, Nakagami, Kazuhiko, Adachi, Moriyasu, Kondo, Naoto, Shibuya, Yasuyuki, Hayashi, Naoki, Naito, Mariko, Yamashita, Toshinari, Umeda, Masahiro, Mukai, Hirofumi, Ota, Yoshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791872/
https://www.ncbi.nlm.nih.gov/pubmed/33413212
http://dx.doi.org/10.1186/s12885-020-07746-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791872/
https://www.ncbi.nlm.nih.gov/pubmed/33413212
http://dx.doi.org/10.1186/s12885-020-07746-9

Ejemplares similares